Insmed Innovation Uk Ltd
10934416
Some Concerns
- No accounts filed in last 18 months (-5)
- Loss before tax (-10)
- Current liabilities exceed current assets (-10)
- Going concern doubt noted in accounts (-10)
- 2 outstanding charges (-4)
Details
Compliance
Last accounts
31/12/2024
small
Next accounts due
30/09/2026
Confirmation statement
Last: 02/09/2025
Due 16/09/2026
Industry
Officers
director · Since 20/09/2024
COMPANY DIRECTOR
BRITISH · UNITED KINGDOM · Age 55
Also on 1 other board
Persons with Significant Control
Insmed Incorporated
700, Us Highway 202/206, Bridgewater
Notified 30/06/2023
Former PSCs
Prof Stephen Philip Jackson
Ceased 11/12/2020
Ahren Innovation Capital Holding Limited
Ceased 19/07/2018
Ahren Lp
Ceased 19/08/2019
Ahren Innovation Capital Guernsey (Gp) Limited, In Its Capacity As General Partner Of Ahren Lp.
Ceased 19/08/2019
Ahren Innovation Capital Llp
Ceased 30/06/2023
Charges2 outstanding
ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP
BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
CompanyRankvs 412+ SIC 72110 peers59
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
been prepared in accordance with IFRS as adopted by the UK , subject to any material departures disclosed and explained in the financial statements; ∙ assess the Company 's ability to continue as a going concern, disclosing, as applicable, matters related to going concern; and ∙ use the going concern basis of accounting unless they either intend to liquidate the Company or to cease operations, or
Key FinancialsYear ending 31/12/2021
Turnover
£1.9M
Annual revenue
Net Worth
£5.7M
Balance sheet strength
Cash
—
Cash in the bank
Profit Before Tax
-£972k
Bottom line earnings
Net Current Assets
—
Working capital
Current Assets
£13.6M
Current Liabilities
£8.4M
Admin Expenses
£1.5M
Operating Profit
-£966k
Profit After Tax
-£972k
People Costs
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2021 | 1.61 | -£1.3M |
| 2020 | 139.61 | +£6.4M |
| 2019 | 42.38 | +£387k |
Derived from filed accounts. Not audited figures.